Anti-FC-gamma RIIB receptor antibody and uses therefor

Details for Australian Patent Application No. 2005282720 (hide)

Owner Genentech, Inc.

Inventors Chan, Andrew C.; Wu, Lawren; Shields, Robert L.

Agent Griffith Hack

Pub. Number AU-B-2005282720

PCT Pub. Number WO2006/028956

Priority 60/606,851 02.09.04 US

Filing date 1 September 2005

Wipo publication date 16 March 2006

Acceptance publication date 4 August 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/028956 Priority application(s): WO2006/028956

4 August 2011 Application Accepted

  Published as AU-B-2005282720

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282721-4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms

2005282719-Methods, systems, and data models for describing an electrical device